{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:34:00Z","timestamp":1794411240315,"version":"4.9.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Varicella caused by the primary infection of varicella-zoster virus (VZV) exerts a considerable disease burden globally. Current varicella vaccines consisting of the live-attenuated vOka strain of VZV are generally safe and effective. However, vOka retains full neurovirulence and can establish latency and reactivate to cause herpes zoster in vaccine recipients, raising safety concerns. Here, we rationally design a live-attenuated varicella vaccine candidate, v7D. This virus replicates like wild-type virus in MRC-5 fibroblasts and human PBMCs, the carrier for VZV dissemination, but is severely impaired for infection of human skin and neuronal cells. Meanwhile, v7D shows immunogenicity comparable to vOka both in vitro and in multiple small animal species. Finally, v7D is proven well-tolerated and immunogenic in nonhuman primates. Our preclinical data suggest that v7D is a promising candidate as a safer live varicella vaccine with reduced risk of vaccine-related complications, and could inform the design of other herpes virus vaccines.<\/jats:p>","DOI":"10.1038\/s41467-022-28329-1","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T11:04:53Z","timestamp":1644577493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Development of a skin- and neuro-attenuated live vaccine for varicella"],"prefix":"10.1038","volume":"13","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dequan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinle","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Selariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiong","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-9180","authenticated-orcid":false,"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-6214","authenticated-orcid":false,"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6087-3175","authenticated-orcid":false,"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0179-5266","authenticated-orcid":false,"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"28329_CR1","unstructured":"World Health Organization.\u00a0Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol. Rec. 89, 265\u2013287 (2014)."},{"key":"28329_CR2","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1086\/342963","volume":"186","author":"JW Gnann Jr.","year":"2002","unstructured":"Gnann, J. W. Jr. Varicella-zoster virus: atypical presentations and unusual complications. J. Infect. Dis. 186, S91\u2013S98 (2002).","journal-title":"J. Infect. Dis."},{"key":"28329_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jped.2016.05.001","volume":"92","author":"E Bozzola","year":"2016","unstructured":"Bozzola, E. & Bozzola, M. Varicella complications and universal immunization. J. Pediatr. (Rio J.) 92, 328\u2013330 (2016).","journal-title":"J. Pediatr. (Rio J.)"},{"key":"28329_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJM200003023420906","volume":"342","author":"DH Gilden","year":"2000","unstructured":"Gilden, D. H., Kleinschmidt-DeMasters, B. K., LaGuardia, J. J., Mahalingam, R. & Cohrs, R. J. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342, 635\u2013645 (2000).","journal-title":"N. Engl. J. Med."},{"key":"28329_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/rmv.1789","volume":"24","author":"M Quinlivan","year":"2014","unstructured":"Quinlivan, M. & Breuer, J. Clinical and molecular aspects of the live attenuated Oka varicella vaccine. Rev. Med Virol. 24, 254\u2013273 (2014).","journal-title":"Rev. Med Virol."},{"issue":"Suppl 2","key":"28329_CR6","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1086\/522161","volume":"197","author":"SS Chaves","year":"2008","unstructured":"Chaves, S. S. et al. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J. Infect. Dis. 197(Suppl 2), S170\u2013S177 (2008).","journal-title":"J. Infect. Dis."},{"key":"28329_CR7","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1086\/522125","volume":"197","author":"SA Galea","year":"2008","unstructured":"Galea, S. A. et al. The safety profile of varicella vaccine: a 10-year review. J. Infect. Dis. 197, S165\u2013S169 (2008).","journal-title":"J. Infect. Dis."},{"key":"28329_CR8","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1016\/j.vaccine.2018.08.048","volume":"36","author":"S Morino","year":"2018","unstructured":"Morino, S. et al. Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000\u20132017. Vaccine 36, 5977\u20135982 (2018).","journal-title":"Vaccine"},{"key":"28329_CR9","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1128\/JVI.00998-16","volume":"90","author":"DP Depledge","year":"2016","unstructured":"Depledge, D. P., Yamanishi, K., Gomi, Y., Gershon, A. A. & Breuer, J. Deep sequencing of distinct preparations of the live attenuated varicella-zoster virus vaccine reveals a conserved core of attenuating single-nucleotide polymorphisms. J. Virol. 90, 8698\u20138704 (2016).","journal-title":"J. Virol."},{"key":"28329_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/molbev\/mst210","volume":"31","author":"DP Depledge","year":"2014","unstructured":"Depledge, D. P. et al. Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans. Mol. Biol. Evol. 31, 397\u2013409 (2014).","journal-title":"Mol. Biol. Evol."},{"key":"28329_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1086\/423210","volume":"190","author":"ML Quinlivan","year":"2004","unstructured":"Quinlivan, M. L., Gershon, A. A., Steinberg, S. P. & Breuer, J. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. J. Infect. Dis. 190, 793\u2013796 (2004).","journal-title":"J. Infect. Dis."},{"key":"28329_CR12","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1016\/j.vaccine.2010.06.056","volume":"28","author":"N Goulleret","year":"2010","unstructured":"Goulleret, N., Mauvisseau, E., Essevaz-Roulet, M., Quinlivan, M. & Breuer, J. Safety profile of live varicella virus vaccine (Oka\/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). Vaccine 28, 5878\u20135882 (2010).","journal-title":"Vaccine"},{"key":"28329_CR13","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1016\/j.vaccine.2016.08.044","volume":"34","author":"T Yoshikawa","year":"2016","unstructured":"Yoshikawa, T., Ando, Y., Nakagawa, T. & Gomi, Y. Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan. Vaccine 34, 4943\u20134947 (2016).","journal-title":"Vaccine"},{"key":"28329_CR14","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/infdis\/jit405","volume":"208","author":"S Weinmann","year":"2013","unstructured":"Weinmann, S. et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J. Infect. Dis. 208, 1859\u20131868 (2013).","journal-title":"J. Infect. Dis."},{"key":"28329_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/INF.0b013e3182137e35","volume":"30","author":"C Chun","year":"2011","unstructured":"Chun, C. et al. Laboratory characteristics of suspected herpes zoster in vaccinated children. Pediatr. Infect. Dis. J. 30, 719\u2013721 (2011).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"28329_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"J Leung","year":"2011","unstructured":"Leung, J., Harpaz, R., Molinari, N. A., Jumaan, A. & Zhou, F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin. Infect. Dis. 52, 332\u2013340 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"28329_CR17","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/jama.284.10.1271","volume":"284","author":"RP Wise","year":"2000","unstructured":"Wise, R. P. et al. Postlicensure safety surveillance for varicella vaccine. J. Am. Med. Assoc. 284, 1271\u20131279 (2000).","journal-title":"J. Am. Med. Assoc."},{"key":"28329_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","volume":"19","author":"RG Sharrar","year":"2000","unstructured":"Sharrar, R. G. et al. The postmarketing safety profile of varicella vaccine. Vaccine 19, 916\u2013923 (2000).","journal-title":"Vaccine"},{"key":"28329_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/v12101078","volume":"12","author":"EH Heusel","year":"2020","unstructured":"Heusel, E. H. & Grose, C. Twelve children with varicella vaccine meningitis: neuropathogenesis of reactivated live attenuated varicella vaccine virus. Viruses 12, 1048 (2020).","journal-title":"Viruses"},{"key":"28329_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-981-10-7230-7_7","volume":"1045","author":"T Sadaoka","year":"2018","unstructured":"Sadaoka, T. & Mori, Y. Vaccine development for varicella-zoster virus. Adv. Exp. Med Biol. 1045, 123\u2013142 (2018).","journal-title":"Adv. Exp. Med Biol."},{"key":"28329_CR21","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/INF.0b013e3181a90b16","volume":"28","author":"R Civen","year":"2009","unstructured":"Civen, R. et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr. Infect. Dis. J. 28, 954\u2013959 (2009).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"28329_CR22","doi-asserted-by":"publisher","first-page":"e20182917","DOI":"10.1542\/peds.2018-2917","volume":"144","author":"S Weinmann","year":"2019","unstructured":"Weinmann, S. et al. Incidence of herpes zoster among children: 2003-2014. Pediatrics 144, e20182917 (2019).","journal-title":"Pediatrics"},{"key":"28329_CR23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/infdis\/jiz560","volume":"221","author":"AN Bubak","year":"2019","unstructured":"Bubak, A. N. et al. Varicella zoster virus infection of primary human spinal astrocytes produces intracellular amylin, amyloid-beta, and an amyloidogenic extracellular environment. J. Infect. Dis. 221, 1088\u20131097 (2019).","journal-title":"J. Infect. Dis."},{"key":"28329_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","volume":"99","author":"B Readhead","year":"2018","unstructured":"Readhead, B. et al. Multiscale analysis of independent Alzheimer\u2019s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron 99, 64\u201382.e67 (2018).","journal-title":"Neuron"},{"key":"28329_CR25","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.neuron.2018.11.043","volume":"100","author":"WA Eimer","year":"2018","unstructured":"Eimer, W. A. et al. Alzheimer\u2019s disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 100, 1527\u20131532 (2018).","journal-title":"Neuron"},{"key":"28329_CR26","doi-asserted-by":"publisher","first-page":"16m11312","DOI":"10.4088\/JCP.16m11312","volume":"79","author":"VC Chen","year":"2018","unstructured":"Chen, V. C. et al. Herpes zoster and dementia: a nationwide population-based cohort study. J. Clin. Psychiatry 79, 16m11312 (2018).","journal-title":"J. Clin. Psychiatry"},{"key":"28329_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni, L., Sen, N., Oliver, S. L. & Arvin, A. M. Molecular mechanisms of varicella zoster virus pathogenesis. Nat. Rev. Microbiol 12, 197\u2013210 (2014).","journal-title":"Nat. Rev. Microbiol"},{"key":"28329_CR28","doi-asserted-by":"publisher","first-page":"14086","DOI":"10.1073\/pnas.0706023104","volume":"104","author":"L Zerboni","year":"2007","unstructured":"Zerboni, L. et al. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. Proc. Natl Acad. Sci. USA 104, 14086\u201314091 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28329_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/JVI.72.2.965-974.1998","volume":"72","author":"JF Moffat","year":"1998","unstructured":"Moffat, J. F. et al. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72, 965\u2013974 (1998).","journal-title":"J. Virol."},{"key":"28329_CR30","doi-asserted-by":"publisher","first-page":"e1000971","DOI":"10.1371\/journal.ppat.1000971","volume":"6","author":"Z Zhang","year":"2010","unstructured":"Zhang, Z. et al. Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor. PLoS Pathog. 6, e1000971 (2010).","journal-title":"PLoS Pathog."},{"key":"28329_CR31","doi-asserted-by":"publisher","first-page":"8614","DOI":"10.1128\/JVI.00128-12","volume":"86","author":"A Selariu","year":"2012","unstructured":"Selariu, A. et al. ORF7 of varicella-zoster virus is a neurotropic factor. J. Virol. 86, 8614\u20138624 (2012).","journal-title":"J. Virol."},{"key":"28329_CR32","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/JVI.00127-17","volume":"91","author":"HF Jiang","year":"2017","unstructured":"Jiang, H. F. et al. ORF7 of varicella-zoster virus is required for viral cytoplasmic envelopment in differentiated neuronal cells. J. Virol. 91, e00127\u201300117 (2017).","journal-title":"J. Virol."},{"key":"28329_CR33","doi-asserted-by":"publisher","first-page":"11969","DOI":"10.1073\/pnas.95.20.11969","volume":"95","author":"JF Moffat","year":"1998","unstructured":"Moffat, J. F. et al. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl Acad. Sci. USA 95, 11969\u201311974 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28329_CR34","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.1128\/JVI.76.16.8468-8471.2002","volume":"76","author":"J Moffat","year":"2002","unstructured":"Moffat, J., Ito, H., Sommer, M., Taylor, S. & Arvin, A. M. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J. Virol. 76, 8468\u20138471 (2002).","journal-title":"J. Virol."},{"key":"28329_CR35","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1128\/JVI.80.7.3238-3248.2006","volume":"80","author":"X Che","year":"2006","unstructured":"Che, X., Zerboni, L., Sommer, M. H. & Arvin, A. M. Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo. J. Virol. 80, 3238\u20133248 (2006).","journal-title":"J. Virol."},{"key":"28329_CR36","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1128\/JVI.02666-06","volume":"81","author":"Z Zhang","year":"2007","unstructured":"Zhang, Z. et al. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J. Virol. 81, 9024\u20139033 (2007).","journal-title":"J. Virol."},{"key":"28329_CR37","doi-asserted-by":"publisher","first-page":"e1003896","DOI":"10.1371\/journal.ppat.1003896","volume":"10","author":"M Jones","year":"2014","unstructured":"Jones, M. et al. RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation. PLoS Pathog. 10, e1003896 (2014).","journal-title":"PLoS Pathog."},{"key":"28329_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/jmv.1890380406","volume":"38","author":"CJ Sexton","year":"1992","unstructured":"Sexton, C. J., Navsaria, H. A., Leigh, I. M. & Powell, K. Replication of varicella zoster virus in primary human keratinocytes. J. Med Virol. 38, 260\u2013264 (1992).","journal-title":"J. Med Virol."},{"key":"28329_CR39","doi-asserted-by":"publisher","first-page":"e1007650","DOI":"10.1371\/journal.ppat.1007650","volume":"15","author":"D Jones","year":"2019","unstructured":"Jones, D. et al. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8(+) T cell effector function. Plos Pathog. 15, e1007650 (2019).","journal-title":"Plos Pathog."},{"key":"28329_CR40","doi-asserted-by":"crossref","unstructured":"Mahalingam, R. et al. Current in vivo models of varicella-zoster virus neurotropism. Viruses 11, 502 (2019).","DOI":"10.3390\/v11060502"},{"key":"28329_CR41","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1073\/pnas.0501045102","volume":"102","author":"L Zerboni","year":"2005","unstructured":"Zerboni, L., Ku, C. C., Jones, C. D., Zehnder, J. L. & Arvin, A. M. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl Acad. Sci. USA 102, 6490\u20136495 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28329_CR42","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1128\/jvi.69.9.5236-5242.1995","volume":"69","author":"JF Moffat","year":"1995","unstructured":"Moffat, J. F., Stein, M. D., Kaneshima, H. & Arvin, A. M. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69, 5236\u20135242 (1995).","journal-title":"J. Virol."},{"key":"28329_CR43","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1128\/JCM.38.9.3156-3160.2000","volume":"38","author":"VN Loparev","year":"2000","unstructured":"Loparev, V. N., Argaw, T., Krause, P. R., Takayama, M. & Schmid, D. S. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J. Clin. Microbiol. 38, 3156\u20133160 (2000).","journal-title":"J. Clin. Microbiol."},{"key":"28329_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","volume":"106","author":"I Mellman","year":"2001","unstructured":"Mellman, I. & Steinman, R. M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255\u2013258 (2001).","journal-title":"Cell"},{"key":"28329_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1074-7613(01)00136-4","volume":"14","author":"C Reis e Sousa","year":"2001","unstructured":"Reis e Sousa, C. Dendritic cells as sensors of infection. Immunity 14, 495\u2013498 (2001).","journal-title":"Immunity"},{"key":"28329_CR46","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1097\/00007890-199560120-00025","volume":"60","author":"J Binder","year":"1995","unstructured":"Binder, J. et al. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. Transplantation 60, 1516\u20131524 (1995).","journal-title":"Transplantation"},{"key":"28329_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/eji.1830250329","volume":"25","author":"T Germann","year":"1995","unstructured":"Germann, T. et al. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25, 823\u2013829 (1995).","journal-title":"Eur. J. Immunol."},{"key":"28329_CR48","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/eji.1830260605","volume":"26","author":"JA Gracie","year":"1996","unstructured":"Gracie, J. A. & Bradley, J. A. Interleukin-12 induces interferon-gamma-dependent switching of IgG alloantibody subclass. Eur. J. Immunol. 26, 1217\u20131221 (1996).","journal-title":"Eur. J. Immunol."},{"key":"28329_CR49","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1128\/IAI.67.6.2713-2719.1999","volume":"67","author":"C Cetre","year":"1999","unstructured":"Cetre, C. et al. Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host. Infect. Immun. 67, 2713\u20132719 (1999).","journal-title":"Infect. Immun."},{"key":"28329_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1128\/JVI.02389-15","volume":"90","author":"JE Carpenter","year":"2016","unstructured":"Carpenter, J. E. et al. Defensive perimeter in the central nervous system: predominance of astrocytes and astrogliosis during recovery from varicella-zoster virus encephalitis. J. Virol. 90, 379\u2013391 (2016).","journal-title":"J. Virol."},{"key":"28329_CR51","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1128\/JVI.79.6.3831-3840.2005","volume":"79","author":"BG Klupp","year":"2005","unstructured":"Klupp, B. G. et al. Functional analysis of the pseudorabies virus UL51 protein. J. Virol. 79, 3831\u20133840 (2005).","journal-title":"J. Virol."},{"key":"28329_CR52","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1128\/JVI.77.5.3204-3216.2003","volume":"77","author":"N Nozawa","year":"2003","unstructured":"Nozawa, N. et al. Subcellular localization of herpes simplex virus type 1 UL51 protein and role of palmitoylation in Golgi apparatus targeting. J. Virol. 77, 3204\u20133216 (2003).","journal-title":"J. Virol."},{"key":"28329_CR53","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1128\/JVI.76.2.774-782.2002","volume":"76","author":"T del Rio","year":"2002","unstructured":"del Rio, T., Werner, H. C. & Enquist, L. W. The pseudorabies virus VP22 homologue (UL49) is dispensable for virus growth in vitro and has no effect on virulence and neuronal spread in rodents. J. Virol. 76, 774\u2013782 (2002).","journal-title":"J. Virol."},{"key":"28329_CR54","doi-asserted-by":"publisher","first-page":"8664","DOI":"10.1128\/JVI.00498-06","volume":"80","author":"C Duffy","year":"2006","unstructured":"Duffy, C. et al. Characterization of a UL49-null mutant: VP22 of herpes simplex virus type 1 facilitates viral spread in cultured cells and the mouse cornea. J. Virol. 80, 8664\u20138675 (2006).","journal-title":"J. Virol."},{"key":"28329_CR55","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1128\/jvi.69.11.7087-7098.1995","volume":"69","author":"KS Dingwell","year":"1995","unstructured":"Dingwell, K. S., Doering, L. C. & Johnson, D. C. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J. Virol. 69, 7087\u20137098 (1995).","journal-title":"J. Virol."},{"key":"28329_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.virol.2017.09.002","volume":"512","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Outer nuclear membrane fusion of adjacent nuclei in varicella-zoster virus-induced syncytia. Virology 512, 34\u201338 (2017).","journal-title":"Virology"},{"key":"28329_CR57","doi-asserted-by":"publisher","first-page":"e1004173","DOI":"10.1371\/journal.ppat.1004173","volume":"10","author":"E Yang","year":"2014","unstructured":"Yang, E., Arvin, A. M. & Oliver, S. L. The cytoplasmic domain of varicella-zoster virus glycoprotein H regulates syncytia formation and skin pathogenesis. PLoS Pathog. 10, e1004173 (2014).","journal-title":"PLoS Pathog."},{"key":"28329_CR58","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1128\/JVI.02592-07","volume":"82","author":"M Reichelt","year":"2008","unstructured":"Reichelt, M., Zerboni, L. & Arvin, A. M. Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia. J. Virol. 82, 3971\u20133983 (2008).","journal-title":"J. Virol."},{"key":"28329_CR59","doi-asserted-by":"crossref","unstructured":"Baird, N. L., Zhu, S., Pearce, C. M. & Viejo-Borbolla, A. Current in vitro models to study varicella zoster virus latency and reactivation. Viruses 11, 103 (2019).","DOI":"10.3390\/v11020103"},{"key":"28329_CR60","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3389\/fmicb.2019.01634","volume":"10","author":"L Laemmle","year":"2019","unstructured":"Laemmle, L., Goldstein, R. S. & Kinchington, P. R. Modeling varicella zoster virus persistence and reactivation\u2014closer to resolving a perplexing persistent state. Front. Microbiol. 10, 1634 (2019).","journal-title":"Front. Microbiol."},{"key":"28329_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03569-2","volume":"9","author":"DP Depledge","year":"2018","unstructured":"Depledge, D. P. et al. A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61. Nat. Commun. 9, 1167 (2018).","journal-title":"Nat. Commun."},{"key":"28329_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20031-4","volume":"11","author":"WJD Ouwendijk","year":"2020","unstructured":"Ouwendijk, W. J. D. et al. Varicella-zoster virus VLT-ORF63 fusion transcript induces broad viral gene expression during reactivation from neuronal latency. Nat. Commun. 11, 6324 (2020).","journal-title":"Nat. Commun."},{"key":"28329_CR63","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1128\/JVI.75.13.6183-6192.2001","volume":"75","author":"A Abendroth","year":"2001","unstructured":"Abendroth, A., Morrow, G., Cunningham, A. L. & Slobedman, B. Varicella-zoster virus infection of human dendritic cells and transmission to T cells: Implications for virus dissemination in the host. J. Virol. 75, 6183\u20136192 (2001).","journal-title":"J. Virol."},{"key":"28329_CR64","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/nar\/gni035","volume":"33","author":"S Warming","year":"2005","unstructured":"Warming, S., Costantino, N., Court, D. L., Jenkins, N. A. & Copeland, N. G. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33, e36 (2005).","journal-title":"Nucleic Acids Res."},{"key":"28329_CR65","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1128\/JVI.76.7.3575-3578.2002","volume":"76","author":"H Sato","year":"2002","unstructured":"Sato, H., Pesnicak, L. & Cohen, J. I. Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J. Virol. 76, 3575\u20133578 (2002).","journal-title":"J. Virol."},{"key":"28329_CR66","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/infdis\/167.1.78","volume":"167","author":"PW Lowry","year":"1993","unstructured":"Lowry, P. W. et al. Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction. J. Infect. Dis. 167, 78\u201383 (1993).","journal-title":"J. Infect. Dis."},{"key":"28329_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep20577","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Serological evaluation of immunity to the varicella-zoster virus based on a novel competitive enzyme-linked immunosorbent assay. Sci. Rep. 6, 20577 (2016).","journal-title":"Sci. Rep."},{"key":"28329_CR68","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12250-017-4048-x","volume":"32","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Varicella-zoster virus ORF7 interacts with ORF53 and plays a role in its trans-Golgi network localization. Virol. Sin. 32, 387\u2013395 (2017).","journal-title":"Virol. Sin."},{"key":"28329_CR69","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1007\/s00253-016-7821-0","volume":"100","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Evaluation of immunity to varicella zoster virus with a novel double antigen sandwich enzyme-linked immunosorbent assay. Appl. Microbiol. Biotechnol. 100, 9321\u20139329 (2016).","journal-title":"Appl. Microbiol. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28329-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:03:42Z","timestamp":1669305822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28329-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28329"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28329-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"5 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"824"}}